Cargando…

PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells

Non-alcoholic steatohepatitis (NASH) results, in part, from the interaction of metabolic derangements with predisposing genetic variants, leading to liver-related complications and mortality. The strongest genetic determinant is a highly prevalent missense variant in patatin-like phospholipase domai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rady, Brian, Nishio, Takahiro, Dhar, Debanjan, Liu, Xiao, Erion, Mark, Kisseleva, Tatiana, Brenner, David A., Pocai, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654208/ https://www.ncbi.nlm.nih.gov/pubmed/34879108 http://dx.doi.org/10.1371/journal.pone.0260721

Ejemplares similares

Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
por: Lan, Tian, et al.
Publicado: (2015)

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells
por: Pirazzi, Carlo, et al.
Publicado: (2014)

PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells
por: Bruschi, Francesca Virginia, et al.
Publicado: (2020)

Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells
por: Lee, Hae Lim, et al.
Publicado: (2022)

AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M
por: Tardelli, Matteo, et al.
Publicado: (2017)

Overexpression of Endoglin Modulates TGF-β1-Signalling Pathways in a Novel Immortalized Mouse Hepatic Stellate Cell Line
por: Meurer, Steffen K., et al.
Publicado: (2013)

Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy
por: Thomes, Paul G., et al.
Publicado: (2016)

PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells
por: Bruschi, Francesca Virginia, et al.
Publicado: (2019)

Hepatic progenitors for liver disease: current position
por: Conigliaro, Alice, et al.
Publicado: (2010)

Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012)

Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis
por: Min, Kyounghee, et al.
Publicado: (2023)

Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells
por: Lin, Zesi, et al.
Publicado: (2015)

Primary Alcohol‐Activated Human and Mouse Hepatic Stellate Cells Share Similarities in Gene‐Expression Profiles
por: Liu, Xiao, et al.
Publicado: (2020)

Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
por: Hicks, Daniel F., et al.
Publicado: (2017)

Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
por: Lee, Young-Sun, et al.
Publicado: (2017)

Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro
por: Hübbers, Anna, et al.
Publicado: (2020)

Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver
por: Rashid, S. Tamir, et al.
Publicado: (2012)

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
por: Smagris, Eriks, et al.
Publicado: (2015)

Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation
por: Wilhelm, Annika, et al.
Publicado: (2016)

Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats
por: Koppula, Sushruta, et al.
Publicado: (2017)

Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI‐Visible Nanocarrier Targeting Hepatic Stellate Cells
por: Wu, Jun, et al.
Publicado: (2019)

Anti-fibrotic effects of Cuscuta chinensis with in vitro hepatic stellate cells and a thioacetamide-induced experimental rat model
por: Kim, Jin Seoub, et al.
Publicado: (2017)

AMP‐activated protein kinase regulates lipid metabolism and the fibrotic phenotype of hepatic stellate cells through inhibition of autophagy
por: Chen, Ming, et al.
Publicado: (2017)

Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers
por: Azzam, Menna, et al.
Publicado: (2020)

Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype
por: Chiabotto, Giulia, et al.
Publicado: (2021)

Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells
por: Li, Wenyang, et al.
Publicado: (2022)

Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice
por: Gong, Qianyuan, et al.
Publicado: (2022)

Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma
por: Zhou, Yuan, et al.
Publicado: (2023)

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages
por: Yoon, Yongdae, et al.
Publicado: (2023)

The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism
por: Harada, Sayaka, et al.
Publicado: (2023)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)

Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
por: Velasquez-Mao, Aaron J., et al.
Publicado: (2021)

Anti-Fibrotic Effects of DL-Glyceraldehyde in Hepatic Stellate Cells via Activation of ERK-JNK-Caspase-3 Signaling Axis
por: Samsuzzaman, Md., et al.
Publicado: (2023)

PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice
por: Wang, Yang, et al.
Publicado: (2019)

Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis
por: BasuRay, Soumik, et al.
Publicado: (2019)

Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis
por: Seeßle, Jessica, et al.
Publicado: (2020)

Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation
por: Nagasaki, Atsuhiro, et al.
Publicado: (2020)

Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes
por: Kang, Jieun, et al.
Publicado: (2021)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
por: Nishio, Takahiro, et al.
Publicado: (2022)

Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway
por: Seo, Hye-Young, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t5ntt9v54roeliev9gu1nq7n6o